New York and Brussels, January 6, 2010 – Heartbeat Software, the leading global provider of Key Opinion Leader (KOL) management software and Heartbeat Experts, the leading provider of KOL data and consulting services, more than doubled profit in 2009 and grew KOL revenue by 40%. The privately held company also reports adding 20 new pharmaceutical, biotech, and medical device clients in 2009 and expanded its service offerings to China, Russia, and Brazil.
“We are proud to have thrived in such a difficult economic environment,” said Jonah Meyers, CEO of Heartbeat Software, “Our growth is largely do to our successful expansion geographically across Asia Pacific, Brazil, Russia, India, China and Latin America. Our clients are making huge strides in these regions and we are well positioned to support them.”
According to Larry Cohen, Global EVP at Heartbeat, “Our client’s approach to managing Key Opinion Leaders, or more accurately key stakeholders, is maturing and this has helped to fuel our gowth. KOLs are not only limited to physicians, rather they also include lobyists, regulators, managed care and sick funds, P&T committees, scientists or anyone who influences the development lifecycle of a pharmaceutical product. Traditionally, KOLs have been utilized in relation to marketing and medical affairs strategies, but today we’re seeing our clients untilize Key Opinion Leaders across Market Access and Pricing and Reimbursement strategies as well.”
“In 2009, we stepped up to the challenge of executing for our clients in Emerging Markets such as Russia and Asia,” said Koen Janssen, Gobal VP of Professional Services at Heartbeat. “The management of KOLs is a truly global process and with substantial offices on three continents, we are well equipped to support our clients as they move into more emerging markets in 2010.”
Heartbeat Software and its consulting arm, Heartbeat Experts, is the leading global provider of Key Opinion Leader Management solutions. With offices in six countries and expertise in twelve major therapeutic areas, Heartbeat works with twenty-five of the top thirty pharmaceutical, biotech, and medical device companies on KOL Identification, KOL Segmentation, KOL Profiling, KOL Influence Mapping, KOL Planning, Market Access Identification and Market Access Strategy.
For more information or to schedule a consultation call the U.S. Headquarters at (212) 941-9041 or the European Headquarters at (32) 2 400 00 22.
In today’s healthcare environment, life sciences companies face pricing, reimbursement, policy and regulatory challenges. In meeting these challenges…
A leading pharmaceutical enterprise was conducting several clinical trials in various stages on a compound, and realized…
© 2011 Heartbeat Experts. All rights reserved